{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:47:00Z","timestamp":1783482420174,"version":"3.55.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.yrtph.2022.105219","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T02:19:59Z","timestamp":1657592399000},"page":"105219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk"],"prefix":"10.1016","volume":"134","author":[{"given":"J.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5209-9642","authenticated-orcid":false,"given":"N.","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3854-5685","authenticated-orcid":false,"given":"M.T.","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-101X","authenticated-orcid":false,"given":"G.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Windebank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7640-7120","authenticated-orcid":false,"given":"G.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib47","first-page":"127","article-title":"Allergy to methyldibromoglutaronitrile\/phenoxyethanol (Euxyl k 400): regulatory issues, epidemiology, clinical characteristics, and management. Dermatitis\u202f: contact, atopic, occupational","volume":"22","author":"Aakhus","year":"2011","journal-title":"Drug"},{"key":"10.1016\/j.yrtph.2022.105219_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104805","article-title":"Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials","volume":"118","author":"Api","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yrtph.2007.10.008","article-title":"Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients","volume":"52","author":"Api","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yrtph.2008.05.011","article-title":"Implementation of the dermal sensitization Quantitative Risk Assessment (QRA) for fragrance ingredients","volume":"52","author":"Api","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0536.2010.01701.x","article-title":"A new IFRA Standard on the fragrance ingredient, hydroxyisohexyl 3-cyclohexene carboxaldehyde","volume":"62","author":"Api","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105219_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yrtph.2015.11.013","article-title":"Skin sensitization quantitative risk assessment: a review of underlying assumptions","volume":"74","author":"Basketter","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15569520903351151","article-title":"Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment","volume":"29","author":"Basketter","year":"2010","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2310\/6620.2008.07018","article-title":"Preservatives and skin sensitization quantitative risk assessment","volume":"19","author":"Basketter","year":"2008","journal-title":"Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/jdv.14513","article-title":"Fragrance contact allergens in 5588 cosmetic products identified through a novel smartphone application","volume":"32","author":"Bennike","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0536.1997.tb00400.x","article-title":"Iodopropynyl butylcarbamate: a new contact allergen","volume":"36","author":"Bryld","year":"1997","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/026119290903700605","article-title":"Non-animal approaches for consumer safety risk assessments: unilever's scientific research programme","volume":"37","author":"Carmichael","year":"2009","journal-title":"Altern Lab Anim"},{"issue":"Suppl 3","key":"10.1016\/j.yrtph.2022.105219_bib50","first-page":"89","article-title":"Final report on the amended safety assessment of Propyl Gallate","volume":"26","year":"2007","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0536.2009.01582.x","article-title":"Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers","volume":"61","author":"de Groot","year":"2009","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105219_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tiv.2018.02.017","article-title":"A strategy for systemic toxicity assessment based on non-animal approaches: the Cosmetics Europe Long Range Science Strategy programme","volume":"50","author":"Desprez","year":"2018","journal-title":"Toxicol. Vitro"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ACI.0000000000000373","article-title":"Allergic contact dermatitis in preservatives: current standing and future options","volume":"17","author":"Deza","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib52","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/jdv.12750","article-title":"Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006-2011","volume":"29","author":"Dinkloh","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol.\u202f: JEADV"},{"key":"10.1016\/j.yrtph.2022.105219_bib11","article-title":"Annex V List of preservatives allowed in cosmetics","author":"Directive","year":"2020","journal-title":"EU Cosmetics Directive"},{"issue":"Suppl 7","key":"10.1016\/j.yrtph.2022.105219_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jdv.15944","article-title":"Safety review of phenoxyethanol when used as a preservative in cosmetics","volume":"33","author":"Dr\u00e9no","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"key":"10.1016\/j.yrtph.2022.105219_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fct.2017.12.054","article-title":"Skin sensitisation quantitative risk assessment (QRA) based on aggregate dermal exposure to methylisothiazolinone in personal care and household cleaning products","volume":"112","author":"Ezendam","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.yrtph.2022.105219_bib13","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00204-016-1842-4","article-title":"State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies","volume":"90","author":"Ezendam","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0273-2300(02)00021-1","article-title":"Application of the risk assessment paradigm to the induction of allergic contact dermatitis","volume":"37","author":"Felter","year":"2003","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0536.1999.tb06200.x","article-title":"An update of the risk assessment for methylchloroisothiazolinone\/methylisothiazolinone (MCI\/MI) with focus on rinse-off products","volume":"41","author":"Fewings","year":"1999","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib55","first-page":"3","article-title":"Parabens. Dermatitis\u202f: contact, atopic, occupational","volume":"30","author":"Fransway","year":"2019","journal-title":"Drug"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1440-0960.2012.00941.x","article-title":"Allergic contact stomatitis to dodecyl gallate? A review of the relevance of positive patch test results to gallates","volume":"54","author":"Gamboni","year":"2013","journal-title":"Australas. J. Dermatol."},{"issue":"10","key":"10.1016\/j.yrtph.2022.105219_bib57","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0001-7310(07)70161-8","article-title":"[Sensitization to gallates: review of 46 cases]","volume":"98","author":"Garc\u00eda-Melgares","year":"2007","journal-title":"Actas dermo-sifiliograficas"},{"key":"10.1016\/j.yrtph.2022.105219_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104755","article-title":"Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: a case study with resorcinol","volume":"117","author":"Gautier","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105219_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.13167","article-title":"Skin sensitization: uncertainties, challenges, and opportunities for improved risk assessment","volume":"80","author":"Gilmour","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105219_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yrtph.2016.01.001","article-title":"Opinion of the Scientific Committee on Consumer safety (SCCS) - opinion on the safety of the use of Methylisothiazolinone (MI) (P94), in cosmetic products (sensitisation only)","volume":"76","author":"Gimenez-Arnau","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib58","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jdv.14063","article-title":"Contact allergy to preservatives: ESSCA* results with the baseline series, 2009-2012","volume":"31","author":"Gim\u00e9nez-Arnau","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yrtph.2012.02.007","article-title":"Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation","volume":"63","author":"Goebel","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105219_bib21","series-title":"On Calibration of Modern Neural Networks","author":"Guo","year":"2017"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup\/&gt","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib59","first-page":"115","article-title":"Gallate Contact Dermatitis: Product Update and Systematic Review. Dermatitis\u202f: contact, atopic, occupational","volume":"28","author":"Holcomb","year":"2017","journal-title":"Drug"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cod.12768","article-title":"Contact allergy to methyldibromo glutaronitrile is still of clinical relevance","volume":"77","author":"Kamstrup","year":"2017","journal-title":"Contact dermatitis"},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1600-0536.2002.470601.x","article-title":"The local lymph node assay: past, present and future","volume":"47","author":"Kimber","year":"2002","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches (*)","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00105-019-04517-x","article-title":"[Preservative allergy\u202f: An enduring issue]","volume":"71","author":"Kreft","year":"2020","journal-title":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ics.12212","article-title":"Investigation on formaldehyde release from preservatives in cosmetics","volume":"37","author":"Lv","year":"2015","journal-title":"Int. J. Cosmet. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cod.12062","article-title":"Contact dermatitis caused by iodopropynyl butylcarbamate in Denmark","volume":"69","author":"Martin-Gorgojo","year":"2013","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jdv.12956","article-title":"Prevalence of methylchloroisothiazolinone and methylisothiazolinone contact allergy in facial dermatitis: a single centre Irish study","volume":"30","author":"Murad","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/toxsci\/kfy135","article-title":"Deriving a No expected sensitization induction level for fragrance ingredients without animal testing: an integrated approach applied to specific case studies","volume":"165","author":"Natsch","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105219_bib27","series-title":"Test No. 406","year":"1992"},{"key":"10.1016\/j.yrtph.2022.105219_bib28","series-title":"Test No. 429","year":"2010"},{"key":"10.1016\/j.yrtph.2022.105219_bib29","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","year":"2014"},{"key":"10.1016\/j.yrtph.2022.105219_bib30","series-title":"Guidance Document on the Reporting of Defined Approaches and Individual Information Sources to Be Used within Integrated Approaches to Testing and Assessment (IATA) for Skin Sensitisation","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105219_bib31","series-title":"Test No. 442D","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105219_bib32","series-title":"Test No. 442E","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105219_bib33","series-title":"Test No. 442C","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105219_bib34","series-title":"Guideline No. 497: Defined Approaches on Skin Sensitisation","year":"2021"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib65","first-page":"E50","article-title":"Skin safety and health prevention: an overview of chemicals in cosmetic products","volume":"60","author":"Panico","year":"2019","journal-title":"J. Prev. Med. Hyg."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2007.01150.x","article-title":"Positive rates to propyl gallate on patch testing: a change in trend","volume":"58","author":"Perez","year":"2008","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yrtph.2007.11.004","article-title":"The Research Institute for Fragrance Materials' human repeated insult patch test protocol","volume":"52","author":"Politano","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105219_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.comtox.2018.10.004","article-title":"Probabilistic prediction of human skin sensitiser potency for use in next generation risk assessment","volume":"9","author":"Reynolds","year":"2019","journal-title":"Computational Toxicology"},{"key":"10.1016\/j.yrtph.2022.105219_bib99","unstructured":"SCCNFP (2003). Opinion of the Scientific committee of cosmetic products and non-food products intended for consumers on Methyldibromogltaronitrile P77."},{"key":"10.1016\/j.yrtph.2022.105219_bib68","unstructured":"SCCNFP (2004) The scientific committee on cosmetic products and non-food products intended for consumers. opinion concerning iodopropynyl butylcarbamate COLIPA n\u00b0 P91. In. https:\/\/ec.europa.eu\/health\/archive\/ph_risk\/committees\/sccp\/documents\/out288_en.pdf."},{"key":"10.1016\/j.yrtph.2022.105219_bib69","unstructured":"SCCP (2005) SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS (SCCP). Opinion on Methyldibromo glutaronitrile (sensitisation only). COLIPA n\u00b0 P77. In. https:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_00f.pdf."},{"key":"10.1016\/j.yrtph.2022.105219_bib73","unstructured":"SCCS (2011) Scientific Committee on Consumer Safety (SCCS) OPINION on Fragrance allergens in cosmetic products."},{"key":"10.1016\/j.yrtph.2022.105219_bib95","unstructured":"SCCS (2013). Scientific Committee on Consumer Safety (SCCS) Opinion on Parabens - an updated opinion on butyl and propyl parabens."},{"key":"10.1016\/j.yrtph.2022.105219_bib96","unstructured":"SCCS (2016a). \"SCCS opinion on Methylisothiazolinone (p94) Submission II (Sensitisation only)."},{"key":"10.1016\/j.yrtph.2022.105219_bib97","doi-asserted-by":"crossref","unstructured":"SCCS (2016b). Scientific Committee for Consumer Safety (SCCS) opinion on Phenoxyethanol.","DOI":"10.1016\/j.yrtph.2016.02.020"},{"key":"10.1016\/j.yrtph.2022.105219_bib37","series-title":"Scientific Committee on Consuemr Safety (SCCS) Skin Sensititsation Qunatitative Risk Assessment for Fragrance Ingredients (QRA2)","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105219_bib38","series-title":"The SCCS Notes of Guidance for the Testing of Cosmtic Ingredients and Their Safety Evaluation","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105219_bib39","series-title":"The SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and Thier Safety Evalaution","year":"2021"},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib75","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1365-2133.2011.10253.x","article-title":"Contact allergy to preservatives. Analysis of IVDK data 1996-2009","volume":"164","author":"Schnuch","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib76","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/jdv.15505","article-title":"Clinicians vs. epidemiologists: patch testing with methyldibromo glutaronitrile as a controversial issue","volume":"33","author":"Schnuch","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib77","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/cod.12733","article-title":"The epidemic of methylisothiazolinone: a European prospective study","volume":"76","author":"Schwensen","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cod.12446","article-title":"Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health","volume":"73","author":"Schwensen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105219_bib41","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.fct.2011.10.013","article-title":"Fragrance material review on benzyl alcohol","volume":"50","author":"Scognamiglio","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/DER.0000000000000537","article-title":"Methylchloroisothiazolinone and\/or methylisothiazolinone contact allergies in Thailand","volume":"32","author":"Sukakul","year":"2021","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0536.1995.tb00625.x","article-title":"Lipstick allergic contact dermatitis from gallates","volume":"32","author":"Serra-Baldrich","year":"1995","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib81","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0536.2012.02140.x","article-title":"Follow-up of the monitored levels of preservative sensitivity in Europe: overview of the years 2001-2008","volume":"67","author":"Svedman","year":"2012","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0536.2009.01668.x","article-title":"Temporal trends of preservative allergy in Denmark (1985-2008)","volume":"62","author":"Thyssen","year":"2010","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib83","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0536.2006.01058.x","article-title":"Contact allergy epidemics and their controls","volume":"56","author":"Thyssen","year":"2007","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yrtph.2014.09.009","article-title":"Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA)","volume":"70","author":"Tollefsen","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cod.12750","article-title":"Methylisothiazolinone: the epidemic is declining - but not gone","volume":"76","author":"Urwin","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/cod.12069","article-title":"Risk factors associated with sensitization to hydroxyisohexyl 3-cyclohexene carboxaldehyde","volume":"69","author":"Uter","year":"2013","journal-title":"Contact Dermatitis"},{"issue":"9","key":"10.1016\/j.yrtph.2022.105219_bib86","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/jdv.14423","article-title":"European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013\/14","volume":"31","author":"Uter","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.15875","article-title":"The epidemic of methylisothiazolinone contact allergy in Europe: follow-up on changing exposures","volume":"34","author":"Uter","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"5","key":"10.1016\/j.yrtph.2022.105219_bib87","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/bjd.18946","article-title":"Trends and current spectrum of contact allergy in Central Europe: results of the Information Network of Departments of Dermatology (IVDK) 2007-2018","volume":"183","author":"Uter","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105219_bib43","series-title":"Evaluating Model Calibration in Classification","author":"Vaicenavicius","year":"2019"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cod.13456","article-title":"Allergic contact dermatitis and photosensitivity to methylisothiazolinone and methylchloroisothiazolinone\/methylisothiazolinone: Portrait of an epidemic in Brazil","volume":"82","author":"Villarinho","year":"2020","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib44","first-page":"639","article-title":"The kinetic direct peptide reactivity assay (kDPRA): intra-and inter-laboratory reproducibility in a seven-laboratory ring trial","volume":"37","author":"Wareing","year":"2020","journal-title":"ALTEX-Alternatives to animal experimentation"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib90","first-page":"50","article-title":"North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis\u202f: contact, atopic, occupational","volume":"24","author":"Warshaw","year":"2013","journal-title":"Drug"},{"issue":"6","key":"10.1016\/j.yrtph.2022.105219_bib91","first-page":"303","article-title":"Positive patch-test reactions to iodopropynyl butylcarbamate: retrospective analysis of North American contact dermatitis group data, from 1998 to 2008. Dermatitis\u202f: contact, atopic, occupational","volume":"21","author":"Warshaw","year":"2010","journal-title":"Drug"},{"key":"10.1016\/j.yrtph.2022.105219_bib98","article-title":"Facial Dermatitis in Male Patients Referred for Patch Testing: Retrospective Analysis of North American Contact Dermatitis Group Data, 1994 to 2016","author":"Warshaw","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.yrtph.2022.105219_bib45","first-page":"61","article-title":"Assuring safety without animal testing: unilever's ongoing research programme to deliver novel ways to assure consumer safety","volume":"27","author":"Westmoreland","year":"2010","journal-title":"ALTEX"},{"issue":"4","key":"10.1016\/j.yrtph.2022.105219_bib92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-0536.2002.460404.x","article-title":"Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000)","volume":"46","author":"Wilkinson","year":"2002","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acs.chemrestox.9b00264","article-title":"Predicting drug-induced liver injury with Bayesian machine learning","volume":"33","author":"Williams","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105219_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bjd.13751","article-title":"Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study","volume":"173","author":"Yazar","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105219_bib94","first-page":"118","article-title":"Lip and perioral dermatitis caused by propyl gallate. Dermatitis\u202f: contact, atopic, occupational","volume":"21","author":"Yu","year":"2010","journal-title":"Drug"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:34:31Z","timestamp":1759494871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":91,"alternative-id":["S0273230022001064"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105219","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105219"}}